Skip to main content

Table 1 Participant baseline characteristics

From: The efficacy and safety of ciprofol use for the induction of general anesthesia in patients undergoing gynecological surgery: a prospective randomized controlled study

Patient characteristics

Ciprofol group

(n = 60)

Propofol group

(n = 60)

P-value

Age,year, mean ± SDs

33.9 ± 9.1

33.8 ± 9.6

0.626

Height, cm, mean ± SDs

159.3 ± 3.8

158.5 ± 5.2

0.915

Weight, kg, mean ± SDs

56.9 ± 7.9

54.0 ± 9.1

0.991

BMI, kg/m2, mean ± SDs

22.2 ± 3.2

21.4 ± 2.8

0.909

ASA status, n(%)

 I

32(53.3%)

34(56.7%)

0.732

 II

28(46.7%)

26(43.3%)

0.793

Operative duration, min, mean ± SDs

55.2 ± 20.5

51.4 ± 23.1

0.645

  1. BMI Body mass index, ASA American Society of Anesthesiologists